uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Dabigatran Etexilate Accord
Authorised
Human
Details
EMA number
EMEA/H/C/005639
ATC code
B01AE07
Authorisation
26 May 2023
Revision
3
EMA page
Therapeutic indication
Prevention of venous thromboembolic events
MeSH:
Venous Thromboembolism;Arthroplasty, Replacement
Group:
Antithrombotic agents
Active substances
dabigatran etexilate mesilate
Marketing Authorisation Holder
Accord Healthcare S.L.U.
MAH
Timeline
Filter by authority:
EMA
Dabigatran Etexilate Accord authorised
26 May 2023
authorised
regulatory
Dabigatran Etexilate Accord | uMedical